Artigos

pubmed: lipedema rss NCBI: db=pubmed; Term=lipedema

  • Physiotherapy and rehabilitation applications in lipedema management: A literature review.
    by Esmer M, Schingale FJ, Unal D, Yazıcı MV, Güzel NA on 4 de dezembro de 2020 at 00:44

    Related Articles Physiotherapy and rehabilitation applications in lipedema management: A literature review. Lymphology. 2020;53(2):88-95 Authors: Esmer M, Schingale FJ, Unal D, Yazıcı MV, Güzel NA Abstract Lipedema is a chronic and progressive disease of adipose tissue caused by abnormal fat accumulation in subcutaneous tissue. Although there is no known cure for lipedema, possible complications can be prevented with conservative and surgical treatments. One of the conservative treatment options is physiotherapy and rehabilitation (PR). When the literature is examined, few studies focusing on the efficacy of PR were found for this patient group. The purpose of this review is to provide a better understanding of the effectiveness of PR applications by compiling existing studies. A bibliographic PubMed search was performed for published studies regarding PR in lipedema management in June 2019 including the last 58 years (1951-2019). Articles were chosen by reading the abstracts and subsequently data were analyzed by reading the entire text through full-text resources. A total of 15 studies met inclusion criteria. Results document how lipedema patients are benefited by PR and the effectiveness of different types of PR programs. The current review also showed that complex decongestive physiotherapy, gait training, hydrotherapy, aerobic exercise, and resistance exercise training each have value in the management of lipedema. The effects of PR for the treatment of lipedema are variable among studies, although overall PR seems to be effective in lipedema management. Although physiotherapy applications have a potentially important role in the management of lipedema, they should be used in combination with other treatment modalities. More studies with higher quality are needed to fully demonstrate the effect and efficacy of PR in lipedema patients. PMID: 33190432 [PubMed – in process]

  • Disease progression and comorbidities in lipedema patients – a 10-year retrospective analysis.
    by Ghods M, Georgiou I, Schmidt J, Kruppa P on 4 de dezembro de 2020 at 00:44

    Related Articles Disease progression and comorbidities in lipedema patients – a 10-year retrospective analysis. Dermatol Ther. 2020 Nov 13;:e14534 Authors: Ghods M, Georgiou I, Schmidt J, Kruppa P Abstract BACKGROUND: Multiple associated comorbidities have been described for lipedema patients. Disease diagnosis still remains challenging in many cases and is frequently delayed. OBJECTIVES: The purpose of this study was to determine the most common comorbidities in lipedema patients and the impact of surgical treatment onto disease progression. METHODS: A retrospective assessment of disease-related epidemiologic data was performed for patients who underwent liposuction between July 2009 and July 2019 in a specialized clinic for lipedema surgery. All patients received a standardized questionnaire regarding the clinical history and changes of lipedema-associated symptoms and comorbidities after surgery. 106 patients who underwent a total of 298 liposuction procedures were included in this study after returning the questionnaire fully filled-in. RESULTS: Multiple comorbidities were observed in the assessed collective. The prevalence for obesity, hypothyroidism, migraine and depression were markedly increased in relation to comparable non-lipedema populations. Despite a median body mass index of 31,6 kg/m2 (IQR 26,4 – 38,8), unexpected low prevalence of diabetes (5 %) and dyslipidemia (7 %) were found. Diagnosis and initiation of guideline-appropriate treatment were delayed by years in many patients. After surgical treatment (medium follow-up 20 months, IQR 11 – 42), a significant reduction of lipedema-associated symptoms was demonstrated. CONCLUSIONS: Lipedema occurs with a diversity of associated comorbidities. Therefore, on the basis of available data, the authors suggest the necessity of a multimodal therapy concept for a comprehensive and holistic treatment. Despite a commonly increased BMI, lipedema patients appear to have an advantageous metabolic risk profile. This article is protected by copyright. All rights reserved. PMID: 33184945 [PubMed – as supplied by publisher]

    para ser informado de conteúdo profissional.